Literature DB >> 18166599

Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.

S Guglielmi1, T M Merz, M Gugger, C Suter, L P Nicod.   

Abstract

Polymyositis and interstitial lung diseases, predominantly nonspecific interstitial pneumonia (NSIP), are known to be frequent in antisynthetase syndrome, where anti-aminoacyl-tRNA synthetase antibodies are often identified. An unusual case of acute respiratory distress syndrome, secondary to such proven NSIP of cellular type with predominant CD8 lymphocytes, is described herein. The patient described in the present case study initially had a poor recovery with high dose of steroids, but this was followed by a good improvement after the prescription of tacrolimus and a low dose of prednisone. A precise diagnosis in similar circumstances may be life-saving, allowing the successful application of new immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18166599     DOI: 10.1183/09031936.00014707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

Review 2.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

Review 3.  Antisynthetase syndrome.

Authors:  Elena Katzap; Maria-Louise Barilla-LaBarca; Galina Marder
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

Review 4.  Antisynthetase antibody syndrome: case report and review of the literature.

Authors:  Laura Uribe; Diana Maria Ronderos; Maria Claudia Díaz; Juan Martín Gutierrez; Christina Mallarino; Daniel Gerardo Fernandez-Avila
Journal:  Clin Rheumatol       Date:  2013-02-20       Impact factor: 2.980

5.  Antisynthetase syndrome (ASS) presenting as acute respiratory distress syndrome (ARDS) in a patient without myositis features.

Authors:  Venkat Kiran Kanchustambham; Swetha Saladi; Sarah Mahmoudassaf; Setu Patolia
Journal:  BMJ Case Rep       Date:  2016-12-09

Review 6.  Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.

Authors:  Shiro Matsubara; Koichi Kondo; Keizo Sugaya; Kazuhito Miyamoto
Journal:  Clin Rheumatol       Date:  2012-08-12       Impact factor: 2.980

7.  Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.

Authors:  Leah J Witt; Carley Demchuk; James J Curran; Mary E Strek
Journal:  Pulm Pharmacol Ther       Date:  2016-01-05       Impact factor: 3.410

Review 8.  The lung as a possible target for the immune reaction in myositis.

Authors:  Sonye K Danoff; Livia Casciola-Rosen
Journal:  Arthritis Res Ther       Date:  2011-07-13       Impact factor: 5.156

9.  Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome.

Authors:  Seo-Hyun Kim; I-Nae Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-07-01

10.  Antisynthetase syndrome: An under-recognized cause of interstitial lung disease.

Authors:  Venkata Nagarjuna Maturu; Arjun Lakshman; Amanjit Bal; Varun Dhir; Aman Sharma; Mandeep Garg; Biman Saikia; Ritesh Agarwal
Journal:  Lung India       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.